Smart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery
Journal of Drug Delivery and Therapeutics · 15.03.2026 · 16 (3) · 268-288
DOI: 10.22270/jddt.v16i3.7630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.03.2026. Verfasst von Praveen Bhat und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Diabetic wounds represent a complex clinical challenge arising from the convergence of chronic inflammation, impaired angiogenesis, oxidative stress, neuropathy, infection, and dysregulated extracellular matrix remodeling. Conventional therapies targeting single pathological components have shown limited efficacy, underscoring the need for integrated and mechanistically informed treatment strategies. This review comprehensively examines nanocarrier-mediated drug delivery systems as a transformative platform for diabetic wound management, integrating herbal, synthetic, semi-synthetic and gene-based therapeutics across preclinical and clinical landscapes. Emphasis is placed on the molecular pathophysiology of diabetic wounds and how advanced nanocarrier platforms enable spatiotemporal control, enhanced bioavailability, and pathway-specific modulation of inflammatory, angiogenic, antimicrobial, and regenerative processes. Material-driven functionalities, including stimuli-responsive release and multifunctional hybrid systems are critically discussed in relation to disorder-specific wound phenotypes. Furthermore, the review evaluates current preclinical models, translational barriers and emerging clinical trends, highlighting the importance of patient stratification and precision wound nanomedicine. Collectively, this work positions nanocarrier-based therapeutics as a promising and adaptable approach capable of addressing the biological heterogeneity of diabetic wounds and advancing toward clinically meaningful outcomes. Keywords: angiogenesis; diabetic wounds; gene therapy; herbal therapeutics; nanocarriers; wound healing
Zitieren
APA
Bhat, P., Satapathy, A., Yadav, N., Satapathy, A., Chandrakar, K., Satapathy, A., Bhardwaj, S. K., & Patel, N. (2026). Smart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery. Journal of Drug Delivery and Therapeutics, 16(3), 268-288. https://doi.org/10.22270/jddt.v16i3.7630
Vancouver
Bhat P, Satapathy A, Yadav N, Satapathy A, Chandrakar K, Satapathy A, et al. Smart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery. Journal of Drug Delivery and Therapeutics. 2026;16(3):268-288. doi:10.22270/jddt.v16i3.7630
BibTeX
@article{Bhat2026,
author = {Bhat, Praveen and Satapathy, Abinash and Yadav, Neha and Satapathy, Abhisek and Chandrakar, Kunal and Satapathy, Ansuman and Bhardwaj, Shiv Kumar and Patel, Nikita},
title = {Smart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery},
journal = {Journal of Drug Delivery and Therapeutics},
year = {2026},
volume = {16},
number = {3},
pages = {268--288},
doi = {10.22270/jddt.v16i3.7630}
}
EUVIMED